4-[2-methoxy-3-(5-methyl-1,3,4-oxadiazol-2-yl)anilino]-2-[(1-methylpyrazol-4-yl)amino]pyrimidine-5-carboxylic acid
C19H18N8O4 — CID 171818579
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-methoxy-3-(5-methyl-1,3,4-oxadiazol-2-yl)anilino]-2-[(1-methylpyrazol-4-yl)amino]pyrimidine-5-carboxylic acid
4-[2-methoxy-3-(5-methyl-1,3,4-oxadiazol-2-yl)anilino]-2-[(1-methylpyrazol-4-yl)amino]pyrimidine-5-carboxylic acid (PubChem CID 171818579) has the molecular formula C19H18N8O4 and a molecular weight of 422.41 g/mol. Its IUPAC name is 4-[2-methoxy-3-(5-methyl-1,3,4-oxadiazol-2-yl)anilino]-2-[(1-methylpyrazol-4-yl)amino]pyrimidine-5-carboxylic acid.
Molecular Properties
| Compound Name | 4-[2-methoxy-3-(5-methyl-1,3,4-oxadiazol-2-yl)anilino]-2-[(1-methylpyrazol-4-yl)amino]pyrimidine-5-carboxylic acid |
|---|---|
| PubChem CID | 171818579 |
| Molecular Formula | C19H18N8O4 |
| Molecular Weight | 422.41 g/mol |
| Exact Mass | 422.15 |
| IUPAC Name | 4-[2-methoxy-3-(5-methyl-1,3,4-oxadiazol-2-yl)anilino]-2-[(1-methylpyrazol-4-yl)amino]pyrimidine-5-carboxylic acid |
| SMILES | COc1c(Nc2nc(Nc3cnn(C)c3)ncc2C(=O)O)cccc1-c1nnc(C)o1 |
| InChI | InChI=1S/C19H18N8O4/c1-10-25-26-17(31-10)12-5-4-6-14(15(12)30-3)23-16-13(18(28)29)8-20-19(24-16)22-11-7-21-27(2)9-11/h4-9H,1-3H3,(H,28,29)(H2,20,22,23,24) |
| InChIKey | OVIVHOIWWPMOSO-UHFFFAOYSA-N |
| XLogP | 2.76 |
| TPSA | 153.11 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.41 |
| LogP ≤ 5 | 2.76 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171818579 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.